The Truth About Glucosamine for Dogs
The Truth: Glucosamine-Chondroitin Is Not For Every Dog
Glucosamine and chondroitin are among the most popular pet supplements for joint pain and joint care. Unfortunately, for many dogs, glucosamine doesn't provide the relief they need.
Unlike those supplements, PCQ Pet provides essential nutrients for your cells, to help your pet get fast relief from pain and inflammation.
"Better than Glucosamine"
A breakthrough in synergy of inflammation-balancing nutrients from landmark university research in older dogs, PCQ Pet has been called "better than glucosamine" by world-renowned veterinary research scientists.
Made with plant-based food nutrients that balance inflammatory response, PCQ Pet provides fast acting relief for your best friend.
Landmark Clinical Research
In January 2020, a landmark study on PCQ Pet in older dogs was completed at the Texas A&M Veterinary School:
The university researchers found PCQ Pet, containing PEA, curcumin and quercetin, acted rapidly to balance inflammation in older dogs.
This means PCQ Pet helps dogs run more, with fewer aches and pains.
The Body's Own Anti-Inflammatory
PEA, short for palmitoylethanolamide, is a fatty acid that’s the “body’s own anti-inflammatory”, because it’s made in every cell of every mammal.
PCQ Pet, containing a synergistic, patent-pending complex of PEA, curcumin and quercetin is the only comprehensive food-based nutrition that impacts all three major inflammatory signaling pathways, starting by blocking pro-inflammatory cytokines, interleukins, and NF-kB.
The Effects of Glucosamine-Chondroitin for Dogs
Glucosamine and Chondroitin, here are the conclusions researchers came to in three different studies on the U.S. National Institute of Health site:
Conclusions: "Compared with placebo, glucosamine, chondroitin, and their combination do not reduce joint pain or have an impact on narrowing of joint space. Health authorities and health insurers should not cover the costs of these preparations, and new prescriptions to patients who have not received treatment should be discouraged."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941572/
Conclusions: "Chondroitin or glucosamine alone or combined did not have a clinically relevant effect on perceived joint pain or on joint space narrowing."
https://www.ncbi.nlm.nih.gov/books/NBK79541/
Conclusions: "The results of this trial demonstrate a lack of superiority of Chondroitin/Glucosamine combination therapy over placebo in terms of reducing joint pain and functional impairment in patients with symptomatic knee OA over 6 months."